NAMS
NewAmsterdam Pharma Company N.V.
$38.27
+$0.56(+1.49%)
70
Overall
50
Value
91
Tech
--
Quality
Market Cap
$4.41B
Volume
1.46M
52W Range
$14.06 - $41.47
Target Price
$45.92
Key Metrics Overview
| Market Cap | $4.41B | P/E Ratio | N/A |
| 52W High | $41.47 | 52W Low | $14.06 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | -63.3% | 52W Position | 88.3% |
| Overall Score | 70 | Value Score | 50 |
| Quality Score | -- | Technical Score | 91 |
Growth Analysis
| EPS Current Est | $-1.6 | EPS Next Est | $-2.01 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NAMS | $38.27 | +1.5% | 1.46M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get NewAmsterdam Pharma Company N.V. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW